All practice questions

8270 questions

Question 1961Question →

An established clinic patient, a 42-year-old female with known limited cutaneous systemic sclerosis, presents to discuss worsening symptoms in her hands. She describes increasingly frequent and painful episodes where her fingers turn white, then blue, upon exposure to mild temperature drops. The episodes are now significantly limiting her daily activities. Arrange the following management steps in the correct chronological order of therapeutic escalation, starting from initial baseline management and progressing to interventions for critical, medically refractory ischemia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of therapy escalation for Raynaud phenomenon is: lifestyle modifications, followed by oral calcium channel blockers, addition of oral PDE-5 inhibitors, intravenous prostanoids, and finally digital sympathectomy.
The established algorithm for secondary Raynaud phenomenon dictates a progressive escalation. It begins with universally applicable conservative measures. If symptoms persist, first-line oral monotherapy with a calcium channel blocker is initiated. Refractory cases warrant combination oral therapy, often with a PDE-5 inhibitor. When oral options are exhausted and the patient faces critical ischemia or digital ulcers, inpatient treatment with intravenous prostanoids is required. Finally, digital sympathectomy is a salvage procedure for tissue at immediate risk of necrosis despite maximal medical therapy.

Step-by-Step Solution

1
Identify the condition and establish the baseline severity.
The patient has progressively worsening Raynaud phenomenon secondary to systemic sclerosis.
Establishing the severity determines the starting point of the treatment algorithm.
2
Select the initial, non-pharmacologic intervention.
Implement lifestyle modifications.
Conservative measures (keeping warm, avoiding vasoconstrictors) are universally required as the baseline intervention.
3
Determine the first-line pharmacologic agent.
Initiate an oral dihydropyridine calcium channel blocker.
CCBs are the most effective and well-tolerated oral agents for preventing vasospastic episodes.
4
Identify the next step for disease refractory to monotherapy.
Add a PDE-5 inhibitor to the oral regimen.
Combination oral therapy is indicated to maximize vasodilation before progressing to invasive treatments.
5
Select the treatment for severe, impending tissue loss.
Administer intravenous prostanoids.
Parenteral therapy is strictly reserved for critical ischemia or active digital ulcers that fail oral therapy.
6
Determine the final option for medically refractory cases.
Perform a digital sympathectomy.
Surgical intervention is the last resort to restore perfusion and prevent autoamputation.

Key Concept

The stepwise management of secondary Raynaud phenomenon in Systemic Sclerosis escalates sequentially from conservative lifestyle changes to oral monotherapy, combination oral therapy, intravenous therapy, and ultimately surgical intervention.
Question 1962Question →

A 62-year-old woman with a 10-year history of diffuse cutaneous systemic sclerosis presents to the emergency department with acute-onset shortness of breath and profound fatigue over the last 48 hours. Her medical history includes Raynaud phenomenon, gastroesophageal reflux disease, and mild interstitial lung disease. Her baseline medications include mycophenolate mofetil, omeprazole, and nifedipine. Three weeks ago, she was evaluated by an outside provider for worsening polyarticular joint pain and was started on oral prednisone 60 mg60\text{ mg} daily.

On physical examination, her temperature is 37.6∘C37.6^\circ\text{C} (99.7∘F99.7^\circ\text{F}), blood pressure is 225/115 mmHg225/115\text{ mmHg}, heart rate is 110/min110/\text{min}, and respiratory rate is 26/min26/\text{min}. Pulse oximetry is 92%92\% on room air. Jugular venous distention is present. Pulmonary auscultation reveals bilateral basilar crackles.

Laboratory results are as follows:

TestResultReference Range
Hemoglobin8.2 g/dL8.2\text{ g/dL}12.0−15.5 g/dL12.0-15.5\text{ g/dL}
Platelets85,000/mm385,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Leukocytes9,500/mm39,500/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Blood urea nitrogen52 mg/dL52\text{ mg/dL}7−20 mg/dL7-20\text{ mg/dL}
Creatinine3.4 mg/dL3.4\text{ mg/dL}0.6−1.1 mg/dL0.6-1.1\text{ mg/dL}
Thyroid-stimulating hormone (TSH)0.2 μU/mL0.2\text{ }\mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\text{ }\mu\text{U/mL}
Free T41.2 ng/dL1.2\text{ ng/dL}0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}

Arterial blood gas on room air:

TestResult
pH7.327.32
pCO230 mmHg30\text{ mmHg}
pO265 mmHg65\text{ mmHg}
HCO315 mEq/L15\text{ mEq/L}

A peripheral blood smear demonstrates 3 to 5 schistocytes per high-power field. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiate oral captopril

Answer

Initiate oral captopril
This patient is presenting with scleroderma renal crisis (SRC), a severe and potentially life-threatening complication of systemic sclerosis. SRC is characterized by the acute onset of malignant hypertension, oliguric acute kidney injury, and microangiopathic hemolytic anemia (evidenced by schistocytes on peripheral smear and thrombocytopenia). A major known risk factor for precipitating SRC is the recent use of high-dose corticosteroids (e.g., prednisone >15 mg/day>15\text{ mg/day}), which this patient was prescribed three weeks ago for joint pain. The underlying pathophysiology involves profound activation of the renin-angiotensin-aldosterone system (RAAS) leading to severe vasoconstriction and vascular injury. Therefore, the immediate treatment of choice is a short-acting ACE inhibitor, such as oral captopril. ACE inhibitors are life-saving in this condition and must be initiated promptly, even in the presence of acute kidney injury.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and recent medication history.
A patient with systemic sclerosis, recently started on high-dose prednisone, presents with malignant hypertension (225/115 mmHg225/115\text{ mmHg}), new-onset acute kidney injury, and microangiopathic hemolytic anemia (evidenced by schistocytes and thrombocytopenia).
Identifying the clinical triad and the medication trigger is essential for accurate diagnosis.
2
Establish the underlying diagnosis.
The clinical picture is diagnostic of scleroderma renal crisis (SRC), a life-threatening complication of systemic sclerosis that is frequently precipitated by the use of high-dose glucocorticoids.
Recognizing SRC directs immediate, disease-specific intervention rather than supportive care alone.
3
Determine the most appropriate pharmacotherapy.
The treatment of choice for SRC is the prompt administration of a short-acting ACE inhibitor, such as captopril.
ACE inhibitors reverse the severe renin-angiotensin-aldosterone system activation that drives the crisis, and they must be initiated even in the setting of acute kidney injury.

Key Concept

Scleroderma renal crisis is characterized by acute renal failure, malignant hypertension, and microangiopathic hemolytic anemia. It is often precipitated by high-dose corticosteroid use, and the cornerstone of therapy is immediate ACE inhibitor administration.
Estimated Time:1m 30s
Question 1963Question →

A 28-year-old woman with a known history of systemic lupus erythematosus (SLE) presents to the clinic with bilateral lower extremity edema and new-onset hypertension (blood pressure 152/94 mmHg). A preliminary urine dipstick in the clinic shows 3+ protein. She is suspected of having lupus nephritis. Arrange the following steps in the appropriate clinical sequence for the diagnostic evaluation and long-term pharmacological management of this patient's renal condition, from first to last.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first quantify the proteinuria, then obtain a renal biopsy for histologic classification, followed by induction immunosuppression, and finally transition to maintenance therapy.
The standard of care for new-onset lupus nephritis involves confirming the renal involvement non-invasively, followed strictly by a biopsy before starting toxic immunosuppressive therapies. The biopsy determines the class of disease, which dictates induction therapy. Once the acute flare is controlled, maintenance therapy is used to prevent relapse.

Step-by-Step Solution

1
Quantify proteinuria
Confirms clinically significant renal involvement.
Dipstick results are preliminary; precise quantification is needed to justify invasive procedures.
2
Renal biopsy
Identifies the exact ISN/RPS class of lupus nephritis.
Different classes of lupus nephritis require drastically different treatments (e.g., Class V vs. Class IV).
3
Induction therapy
Rapidly controls severe, active renal inflammation.
Prevents irreversible nephron loss and progression to end-stage renal disease.
4
Maintenance therapy
Sustains long-term remission.
Minimizes the cumulative toxicity of high-dose steroids and potent immunosuppressants.

Key Concept

The management of suspected lupus nephritis follows a strict sequence: confirm renal involvement with non-invasive testing, perform a biopsy to establish the histologic class, initiate potent induction therapy for active disease, and follow with lower-toxicity maintenance therapy.
Question 1964Question →

Match the following clinical scenarios with their most likely primary acid-base disturbance.

Click a left item, then click its matching right item

Items

A 22-year-old man with polyuria, abdominal pain, Kussmaul respirations, and a blood glucose of 450450 mg/dL.
A 68-year-old man with a severe exacerbation of chronic obstructive pulmonary disease and worsening somnolence.
A 45-year-old woman with intractable vomiting for 33 days due to a suspected gastric outlet obstruction.
A 30-year-old woman with acute shortness of breath, perioral numbness, and carpopedal spasm following a stressful event.

Matches

Show answer & explanation

Answer

The clinical scenarios correctly match their corresponding primary acid-base disturbances based on their distinct pathophysiological mechanisms (e.g., ketoacid accumulation, hypoventilation, gastric acid loss, and hyperventilation).
Each matching pair correctly identifies the cardinal acid-base disturbance associated with the patient's acute pathology. Diabetic ketoacidosis generates unmeasured anions (metabolic acidosis). Hypoventilation in COPD retains CO2CO_2 (respiratory acidosis). Gastric acid loss from vomiting removes HClHCl (metabolic alkalosis). Hyperventilation from a panic attack expires excess CO2CO_2 (respiratory alkalosis).

Step-by-Step Solution

1
Identify the underlying mechanism of acid-base disruption in each clinical vignette.
Diabetic ketoacidosis produces ketoacids, severe COPD impairs ventilation, vomiting depletes gastric acid, and panic attacks cause hyperventilation.
Determining the primary physiological insult is required to identify the initial acid-base disorder.

Key Concept

Pathophysiology and identification of primary acid-base disorders
Question 1965Question →

An 82-year-old female resident of a skilled nursing facility presents for a routine wellness examination. The nursing staff reports that her urine has appeared cloudy and foul-smelling over the past three days. However, the patient denies any dysuria, urinary frequency, urinary urgency, flank pain, or changes in her cognitive baseline. Her temperature is 37.0°C (98.6°F), blood pressure is 128/78 mm Hg, and pulse is 72/min. Physical examination reveals a soft, non-tender abdomen without suprapubic or costovertebral angle tenderness. A clean-catch urinalysis reveals positive leukocyte esterase, positive nitrites, and 45 leukocytes/hpf. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Observation without antibiotic therapy

Answer

Observation without antibiotic therapy
The correct management for this patient is observation without antibiotic therapy. She has asymptomatic bacteriuria (ASB), which is defined as the presence of bacteria in the urine without typical signs or symptoms of a urinary tract infection (e.g., dysuria, urgency, frequency, suprapubic pain, or fever). ASB is highly prevalent among elderly patients, especially those in long-term care facilities. Cloudy or foul-smelling urine is often reported by caregivers but is not a reliable indicator of symptomatic infection and should not independently prompt treatment. According to infectious disease guidelines, ASB should not be screened for or treated except in specific populations (e.g., pregnant women, patients undergoing invasive urologic procedures). Treating ASB in this demographic does not prevent future symptomatic urinary tract infections or improve mortality; instead, it violates antibiotic stewardship by increasing the risk of multi-drug resistant organisms, adverse drug effects, and Clostridioides difficile infections.

Step-by-Step Solution

1
Evaluate the patient's symptoms in the context of the urinalysis findings.
The patient has abnormal urinalysis findings (pyuria, bacteriuria) but completely lacks clinical symptoms of a urinary tract infection (no dysuria, frequency, fever, or confusion).
Differentiating between asymptomatic bacteriuria and a symptomatic urinary tract infection is the critical branch point for deciding whether antimicrobial therapy is necessary.
2
Determine the appropriate management based on current infectious disease guidelines.
The diagnosis is asymptomatic bacteriuria, which should be managed with observation rather than antibiotics.
Treating asymptomatic bacteriuria does not improve clinical outcomes and increases the risk of adverse drug reactions, antibiotic resistance, and Clostridioides difficile infection.

Key Concept

Management of Asymptomatic Bacteriuria
Question 1966Question →

A 71-year-old woman is brought to the emergency department by her daughter due to a 3-day history of progressively worsening headache, dizziness, and blurry vision. The patient also reports having a severe nosebleed this morning that lasted for 30 minutes. Over the past 6 months, she has experienced significant fatigue and a 5-kg (11-lb) weight loss. She has no prior medical conditions and takes no medications. Vital signs are temperature 37.1°C (98.8°F), blood pressure 130/80 mm Hg, pulse 92/min, and respirations 16/min. Physical examination reveals conjunctival pallor and painless, rubbery cervical lymphadenopathy. Funduscopic examination demonstrates bilateral dilated, tortuous retinal veins with scattered flame-shaped hemorrhages. Laboratory studies show:

Hemoglobin: 8.2 g/dL
Platelets: 135,000/mm³
Leukocytes: 6,800/mm³
Blood urea nitrogen: 18 mg/dL
Serum creatinine: 1.0 mg/dL
Total protein: 11.2 g/dL
Albumin: 3.4 g/dL

Serum protein electrophoresis reveals a sharp localized band in the gamma region. Immunofixation electrophoresis confirms this is a monoclonal IgM kappa protein. Which of the following is the most appropriate next step in management for this patient?

Show answer & explanation

Answer: Therapeutic plasma exchange

Answer

Therapeutic plasma exchange is the most appropriate next step to urgently resolve symptomatic hyperviscosity.
This patient's presentation of headache, dizziness, blurry vision, epistaxis, and 'sausage-link' (dilated and tortuous) retinal veins in the setting of a large monoclonal IgM spike is highly characteristic of hyperviscosity syndrome due to Waldenström macroglobulinemia (WM). IgM is a large pentameric immunoglobulin that significantly increases serum viscosity when present in high concentrations. This leads to impaired microcirculation, causing central nervous system symptoms and retinal venous engorgement. The most appropriate next step in management for symptomatic hyperviscosity is urgent therapeutic plasma exchange (plasmapheresis), which rapidly removes the IgM from the intravascular space and resolves the symptoms. Following stabilization, further diagnostic workup (e.g., bone marrow biopsy) and systemic chemotherapy can be pursued.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has headache, dizziness, vision changes, mucosal bleeding, retinal venous engorgement, and a large monoclonal IgM spike.
To establish the primary pathophysiology causing the patient's acute symptoms.
2
Diagnose the underlying condition and its acute complication.
The diagnosis is hyperviscosity syndrome secondary to Waldenström macroglobulinemia.
IgM is a large pentameric molecule; high levels significantly increase blood viscosity, leading to impaired microcirculation.
3
Determine the most appropriate immediate management.
Select therapeutic plasma exchange (plasmapheresis).
Mechanical removal of the IgM pentamers via plasmapheresis is required to rapidly reverse the potentially life-threatening neurologic and ocular complications of hyperviscosity.

Key Concept

Symptomatic hyperviscosity syndrome in Waldenström macroglobulinemia (IgM monoclonal gammopathy) is an oncologic emergency that requires immediate treatment with therapeutic plasma exchange.
Question 1967Question →

A 6161-year-old man comes to the clinic for evaluation of frequent headaches, dizziness, and generalized pruritus that severely worsens after he takes a warm shower. He has a history of mild chronic obstructive pulmonary disease (COPD) and a 3535-pack-year smoking history. Vital signs show a blood pressure of 148/92 mm Hg148/92\text{ mm Hg}, pulse of 82/min82/\text{min}, and respiratory rate of 14/min14/\text{min}. Pulse oximetry is 96%96\% on room air. Physical examination reveals a ruddy facial complexion and a palpable spleen tip 3 cm3\text{ cm} below the left costal margin. Laboratory studies reveal the following:

MeasurementResultReference Range
Hemoglobin19.5 g/dL19.5\text{ g/dL}13.5−17.5 g/dL13.5-17.5\text{ g/dL}
Hematocrit61%61\%41%−53%41\%-53\%
Leukocytes14,800/mm314,800/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Platelets550,000/mm3550,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Serum erythropoietinLowNormal

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate therapeutic phlebotomy

Answer

Initiate therapeutic phlebotomy
The correct answer is to initiate therapeutic phlebotomy. This patient's presentation of aquagenic pruritus (severe itching after a warm shower), facial plethora, headaches, and splenomegaly is highly classic for Polycythemia Vera (PV). The laboratory findings of panmyelosis (elevated hemoglobin, leukocytes, and platelets) combined with a low serum erythropoietin (EPO) level secure the diagnosis of primary polycythemia over secondary causes. PV is driven by an activating mutation in the JAK2 kinase, leading to EPO-independent proliferation of myeloid cell lines. The primary morbidity and mortality in PV arise from hyperviscosity-induced thrombosis. Therefore, the immediate next step in management is therapeutic phlebotomy to lower the hematocrit to less than 45%45\%, which significantly reduces the risk of thrombotic complications.

Step-by-Step Solution

1
Analyze the patient's classic symptoms and physical exam findings.
The patient has aquagenic pruritus (itching after a warm shower), headaches, dizziness, a ruddy complexion (plethora), and splenomegaly.
These are hallmark clinical features of hyperviscosity and histamine release associated with myeloproliferative neoplasms.
2
Evaluate the complete blood count and serum erythropoietin levels.
The labs show panmyelosis (elevated red blood cells, white blood cells, and platelets) alongside a low serum erythropoietin (EPO) level.
A low EPO level distinguishes primary polycythemia (Polycythemia Vera) from secondary polycythemia, where EPO would be elevated due to chronic hypoxia or an EPO-secreting tumor.
3
Determine the most appropriate initial management for the diagnosed condition.
The patient requires immediate reduction of red cell mass via therapeutic phlebotomy.
Lowering the hematocrit to below 45% is critical in Polycythemia Vera to mitigate the high risk of fatal thrombotic events (e.g., stroke, myocardial infarction).

Key Concept

Polycythemia Vera is a primary myeloproliferative neoplasm characterized by panmyelosis, a low serum erythropoietin level, and classic symptoms like aquagenic pruritus. Initial management is therapeutic phlebotomy to lower the hematocrit and reduce thrombotic risk.
Question 1968Question →

Match each clinical presentation of a child's current developmental abilities with their most accurate estimated developmental age.

Click a left item, then click its matching right item

Items

Stands independently, uses a mature pincer grasp, and says 1 word besides 'mama' and 'dada', but is unable to run or walk up stairs with a hand held.
Jumps with both feet, builds a tower of 6 blocks, and uses 2-word phrases, but is unable to copy a circle or ride a tricycle.
Rides a tricycle, copies a circle, and speaks in 3-word sentences, but is unable to draw a person with 3 parts or hop on one foot.
Walks down stairs alternating feet, copies a cross, and engages in cooperative play, but is unable to skip or tie shoelaces.
Skips, copies a square, dresses independently, and draws a person with 6 parts, but is unable to draw a diamond.

Matches

Show answer & explanation

Answer

The correct matches align each specific combination of achieved milestones (and notably absent skills) with the standard pediatric developmental timeline for ages 1 through 5 years.
Each age strictly corresponds to specific milestones achieved in the gross motor, fine motor, language, and social domains. The negative findings (skills the child cannot yet do) serve as upper bounds, perfectly isolating the correct developmental year.

Step-by-Step Solution

1
Evaluate the profile of the child who is standing independently, using a mature pincer grasp, and speaking 1 word.
Matches 12 months (1 year).
These are classic 1-year milestones. The inability to run confirms the child has not yet reached the 18-month developmental stage.
2
Evaluate the profile of jumping, building a 6-block tower, and using 2-word phrases.
Matches 24 months (2 years).
These define the 2-year mark. The absence of tricycle riding and circle copying rules out a 36-month developmental age.
3
Assess the abilities to ride a tricycle, copy a circle, and use 3-word sentences.
Matches 36 months (3 years).
These represent core 3-year milestones, supported by the lack of 48-month skills like hopping on one foot.
4
Identify walking down stairs alternating feet, copying a cross, and engaging in cooperative play.
Matches 48 months (4 years).
These are defining 4-year milestones. Skipping and tying shoes are absent, which rules out the 60-month stage.
5
Correlate skipping, copying a square, and drawing a 6-part person.
Matches 60 months (5 years).
These are 5-year milestones. Copying a diamond is expected later, at around 6 years of age.

Key Concept

Normal Pediatric Growth and Development Milestones
Estimated Time:2m 0s
Question 1969Question →

Following a week-long camping excursion in Rhode Island, a 34-year-old woman presents to an urgent care clinic with a 4-day history of sudden-onset high fever, profound fatigue, severe headache, and diffuse muscle pain. She has no significant past medical history and takes no medications. Her temperature is 38.9°C (102°F), blood pressure is 112/72 mmHg, and pulse is 98/min. Physical examination reveals no skin rashes, eschars, lymphadenopathy, or joint swelling. Sclerae are anicteric. Laboratory evaluation shows:

TestResult
Hemoglobin13.5 g/dL
Leukocyte count2,400/mm³
Platelet count78,000/mm³
Total bilirubin0.9 mg/dL
Aspartate aminotransferase (AST)115 U/L
Alanine aminotransferase (ALT)108 U/L

A peripheral blood smear is examined and reveals no intraerythrocytic inclusions. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate oral doxycycline therapy

Answer

Initiate oral doxycycline therapy
The clinical presentation of acute fever, headache, and myalgias in a patient returning from a highly endemic area, combined with the classic laboratory triad of leukopenia, thrombocytopenia, and elevated transaminases, is highly suspicious for human granulocytic anaplasmosis. The absence of a rash makes Lyme disease less likely, and the absence of hemolytic anemia (normal hemoglobin and bilirubin) alongside a negative peripheral blood smear (no Maltese crosses or intraerythrocytic rings) effectively rules out babesiosis. Because anaplasmosis can progress to severe complications such as respiratory failure or toxic shock-like syndrome, empiric therapy with doxycycline must be initiated immediately upon clinical suspicion. Confirmatory testing (e.g., PCR or serology) should be ordered, but treatment must never be delayed while waiting for the results.

Step-by-Step Solution

1
Analyze the patient's exposure history and clinical presentation.
The patient has a history of tick exposure in an endemic area (Rhode Island) presenting with an acute febrile illness, severe myalgias, and headache without a rash.
Identifying the geographic and clinical context narrows the differential diagnosis to tick-borne illnesses such as Lyme disease, anaplasmosis, and babesiosis.
2
Evaluate the laboratory findings to differentiate between the potential tick-borne pathogens.
Labs show the classic triad of leukopenia, thrombocytopenia, and elevated transaminases. The absence of anemia, normal bilirubin, and negative blood smear make babesiosis highly unlikely.
This specific laboratory triad is the hallmark of human granulocytic anaplasmosis, caused by Anaplasma phagocytophilum.
3
Determine the most appropriate management based on the suspected diagnosis.
Empiric oral doxycycline is selected as the optimal initial step.
Anaplasmosis can cause severe complications if untreated. Therapy with doxycycline must be started based on clinical suspicion and not delayed for confirmatory testing.

Key Concept

Clinical presentation and empiric management of human granulocytic anaplasmosis
Question 1970Question →

A 24-year-old man presents to the clinic with a 2-month history of profound fatigue, intermittent fevers, and drenching night sweats. Physical examination reveals a 4-cm, painless, rubbery right supraclavicular lymph node. A preliminary CT scan of the neck and chest confirms the presence of an isolated 4.2-cm right supraclavicular lymph node without significant mediastinal or axillary lymphadenopathy. Laboratory studies show a normal complete blood count, but the erythrocyte sedimentation rate is elevated at 65 mm/hr.

Arrange the following steps in the most appropriate sequential order for the definitive diagnosis, staging, and management of this patient's most likely condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Excisional biopsy of the lymph node, 2) Whole-body FDG-PET/CT for staging, 3) Baseline echocardiogram and pulmonary function tests, 4) Initiation of ABVD chemotherapy, and 5) Interim FDG-PET/CT for response assessment.
This sequence perfectly outlines the standard of care for a young patient presenting with B symptoms and localized lymphadenopathy highly suspicious for Hodgkin lymphoma. Diagnosis must precede staging; staging and safety evaluations must precede treatment; and treatment must precede response assessment.

Step-by-Step Solution

1
Select excisional biopsy as the first action.
Establishes tissue diagnosis of classical Hodgkin Lymphoma.
Malignancy must always be proven histologically before undertaking expensive staging or toxic therapies. Excisional biopsy is preferred over fine-needle aspiration for lymphoma to preserve nodal architecture.
2
Select FDG-PET/CT scan as the second action.
Determines the clinical stage of the disease.
Once the diagnosis is established, staging is required to define the exact extent of disease, which dictates the prognosis and the specific treatment algorithm.
3
Select baseline organ function evaluation (Echocardiogram and PFTs) as the third action.
Ensures the patient can safely receive the planned chemotherapy.
The ABVD regimen contains doxorubicin (cardiotoxic) and bleomycin (pulmonary toxic). Baseline parameters must be documented before the first dose is administered.
4
Select initiation of ABVD chemotherapy as the fourth action.
Begins curative-intent treatment.
Treatment can safely commence only after diagnosis, staging, and safety evaluations are completed.
5
Select interim FDG-PET/CT scan as the final action.
Evaluates early response to the chemotherapy.
Modern management of Hodgkin lymphoma utilizes interim PET imaging (typically after 2 cycles) to guide whether subsequent therapy should be escalated or de-escalated to minimize long-term toxicity.

Key Concept

The sequential management of Hodgkin lymphoma mandates tissue diagnosis via excisional biopsy, accurate staging with PET/CT, pre-treatment baseline organ function assessment (tailored to expected chemotherapy toxicities), initiation of systemic therapy, and early response monitoring via interim imaging.
Estimated Time:2m 0s
Question 1971Question →

An 11-year-old girl is brought to the pediatric clinic by her father for a routine well-child visit. The father mentions that he has noticed recent changes in his daughter's physical appearance and is wondering what to expect regarding her development over the next few years. The patient is otherwise healthy, eats a well-balanced diet, and plays competitive soccer. Her height is at the 60th percentile and her weight is at the 55th percentile. On physical examination, the breast and papilla are elevated as a small mound, and the areolar diameter is enlarged. Examination of the genitalia reveals sparse, straight, lightly pigmented hair primarily along the medial border of the labia. The remainder of the examination is unremarkable. Based on these findings, which of the following is the most accurate anticipatory guidance to provide to this family?

Show answer & explanation

Answer: Menarche is expected to occur in approximately 2 to 2.5 years.

Answer

Menarche is expected to occur in approximately 2 to 2.5 years.
The correct answer accurately reflects the normal timeline of female pubertal development. This 11-year-old patient's physical examination reveals Tanner stage II breast development (thelarche) and Tanner stage II pubic hair development (pubarche). In females, thelarche is typically the first sign of puberty, occurring normally between 8 and 13 years of age. Menarche is usually a late pubertal event that occurs during Tanner stage IV, on average 2 to 2.5 years after the initial onset of breast budding. Therefore, informing the father that menarche is expected in approximately 2 to 2.5 years is the most appropriate and accurate anticipatory guidance.

Step-by-Step Solution

1
Determine the patient's current stage of pubertal development.
The physical exam describes breast and papilla elevated as a small mound (Tanner stage II) and sparse, straight pubic hair (Tanner stage II).
Accurate Tanner staging is required to predict the timeline of future pubertal events.
2
Recall the normal sequence of female pubertal development.
The typical sequence is Thelarche (breast budding) -> Pubarche/Adrenarche (pubic/axillary hair) -> Peak height velocity -> Menarche.
Understanding the sequence allows for identifying what milestone will happen next.
3
Identify the standard time interval between initial breast budding and menarche.
Menarche typically occurs at Tanner stage IV, which is about 2 to 2.5 years after the onset of thelarche (Tanner stage II).
This specific time interval provides the basis for correct anticipatory guidance.

Key Concept

Normal sequence and timing of female pubertal development (Tanner staging).
Estimated Time:1m 0s
Question 1972Question →

During a wellness evaluation, a 42-year-old woman reports a recent onset of episodic, severe muscle weakness. Over the past month, she has experienced profound difficulty rising from a chair and climbing stairs. She also notes a two-year history of a "sandy" sensation in her eyes requiring daily artificial tears, as well as multiple new dental caries despite good oral hygiene. She takes no medications and denies diarrhea or diuretic use. Vital signs are within normal limits. Physical examination reveals an erythematous, dry oral mucosa and 3/53/5 muscle strength in the bilateral lower extremities with diminished deep tendon reflexes.

Initial laboratory studies reveal the following:

ParameterResult
Sodium140 mEq/L140 \text{ mEq/L}
Potassium2.1 mEq/L2.1 \text{ mEq/L}
Chloride115 mEq/L115 \text{ mEq/L}
Bicarbonate13 mEq/L13 \text{ mEq/L}
Blood urea nitrogen14 mg/dL14 \text{ mg/dL}
Creatinine0.8 mg/dL0.8 \text{ mg/dL}
Urine pH6.56.5

Which of the following diagnostic tests is most likely to confirm the underlying systemic etiology of this patient's presentation?

Show answer & explanation

Answer: Assay for anti-Ro/SSA and anti-La/SSB antibodies

Answer

Assay for anti-Ro/SSA and anti-La/SSB antibodies
The patient's presentation is highly characteristic of primary Sjögren syndrome complicated by Type 1 (distal) renal tubular acidosis (RTA). Sjögren syndrome presents with classic sicca symptoms, including keratoconjunctivitis sicca (dry, 'sandy' eyes) and xerostomia (dry mouth leading to rampant dental caries). A well-documented extra-glandular manifestation of Sjögren syndrome is Type 1 RTA. This occurs due to autoimmune tubulointerstitial damage that impairs hydrogen ion secretion in the distal nephron. This impairment leads to a non-anion gap metabolic acidosis with an inappropriately high urine pH (typically greater than 5.5). The defective hydrogen secretion is coupled with severe renal potassium wasting, resulting in profound hypokalemia. Clinically, this severe hypokalemia manifests as acute muscle weakness and hyporeflexia, which can mimic a primary myopathy. Assaying for anti-Ro/SSA and anti-La/SSB antibodies is the most appropriate next step to confirm the underlying diagnosis of Sjögren syndrome.

Step-by-Step Solution

1
Identify the primary clinical syndrome from the patient's history.
The patient has prominent sicca symptoms (dry eyes, dry mouth, rampant dental caries), which strongly suggests Sjögren syndrome.
Recognizing the sicca complex narrows the differential diagnosis to specific systemic autoimmune diseases.
2
Analyze the acid-base and electrolyte derangements in the laboratory results.
The patient has severe hypokalemia (2.1 mEq/L2.1 \text{ mEq/L}) and a non-anion gap metabolic acidosis (Anion gap = 140−(115+13)=12140 - (115 + 13) = 12).
The profound hypokalemia is the direct cause of her acute proximal muscle weakness and hyporeflexia.
3
Determine the specific cause of the metabolic acidosis using the urine pH.
The inappropriately high urine pH (6.56.5) in the setting of a non-anion gap metabolic acidosis points to Type 1 (distal) renal tubular acidosis (RTA).
Type 1 RTA involves a failure of the distal tubule to secrete hydrogen ions, leading to basic urine, acidosis, and secondary potassium wasting.
4
Synthesize the findings to select the confirmatory diagnostic test.
Sjögren syndrome is a classic cause of acquired Type 1 RTA. Assaying for anti-Ro/SSA and anti-La/SSB antibodies confirms the diagnosis.
Linking the extra-glandular renal manifestation to the primary autoimmune disease dictates the next best step in diagnosis.

Key Concept

Sjögren syndrome can cause tubulointerstitial inflammation leading to Type 1 (distal) renal tubular acidosis, which presents with a non-anion gap metabolic acidosis, inappropriately high urine pH, and severe hypokalemia that can cause profound muscle weakness.
Estimated Time:1m 30s
Question 1973Question →

An 78-year-old man is evaluated for sudden-onset shortness of breath. He was admitted to the hospital earlier today for symptomatic anemia secondary to chronic gastrointestinal blood loss. His medical history is significant for ischemic heart disease, hypertension, and chronic obstructive pulmonary disease. Two hours ago, a transfusion of packed red blood cells was initiated. Current vital signs include a temperature of 37.2∘C37.2^\circ\text{C} (99.0∘F99.0^\circ\text{F}), blood pressure of 172/96 mmHg172/96 \text{ mmHg}, pulse of 114/min114/\text{min}, and respiratory rate of 28/min28/\text{min}. Pulse oximetry shows an oxygen saturation of 85%85\% on room air. Physical examination reveals visibly distended neck veins. Lung auscultation demonstrates bilateral bibasilar crackles extending to the mid-lung fields, as well as scattered expiratory wheezes. Cardiac auscultation reveals a regular rhythm with an audible S3 gallop. The transfusion is immediately stopped and supplemental oxygen is provided. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Administer intravenous furosemide

Answer

The most appropriate next step is to administer intravenous furosemide to manage the acute volume overload.
The patient is experiencing Transfusion-Associated Circulatory Overload (TACO), a common complication in elderly patients or those with underlying cardiopulmonary disease receiving blood products. The presentation is characterized by acute respiratory distress, hypertension, tachycardia, and signs of fluid overload such as jugular venous distension, an S3 gallop, and pulmonary crackles. The definitive initial management is to stop the transfusion, provide supplemental oxygen, and administer loop diuretics, such as intravenous furosemide, to rapidly reduce intravascular volume.

Step-by-Step Solution

1
Analyze the timing and context of the patient's respiratory distress.
The acute dyspnea and hypoxia occurred directly during the transfusion of a blood product.
Establishing the temporal relationship strongly indicates an acute transfusion reaction.
2
Evaluate vital signs and physical examination findings to distinguish the specific type of transfusion reaction.
The patient exhibits marked hypertension (172/96 mmHg172/96 \text{ mmHg}), jugular venous distension, an S3 gallop, and bilateral pulmonary crackles.
These findings specifically indicate a cardiogenic cause of pulmonary edema and volume overload, ruling out Transfusion-Related Acute Lung Injury (TRALI), which typically presents with hypotension and no signs of right-sided heart strain.
3
Determine the most appropriate immediate medical intervention based on the diagnosis of Transfusion-Associated Circulatory Overload (TACO).
The standard of care requires immediate cessation of the transfusion and administration of intravenous loop diuretics.
Loop diuretics rapidly decrease intravascular volume and alleviate pulmonary congestion, correcting the underlying hydrostatic pressure derangement.

Key Concept

Diagnosis and management of Transfusion-Associated Circulatory Overload (TACO)
Question 1974Question →

A 32-year-old man presents to the outpatient clinic with a 4-day history of nasal congestion, rhinorrhea, and a bothersome dry cough. He states the cough occasionally keeps him awake at night. He reports feeling mildly fatigued but has had no fever, chills, or shortness of breath. The patient has no significant past medical history and takes no daily medications. Vital signs are temperature 37.0 °C (98.6 °F), blood pressure 122/78 mmHg, pulse 76/min, and respiratory rate 14/min. Physical examination reveals erythematous nasal mucosa and a clear posterior pharynx. Auscultation of the lungs reveals clear breath sounds bilaterally with no wheezes, rhonchi, or crackles. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Provide reassurance and recommend symptomatic treatment

Answer

Provide reassurance and recommend symptomatic treatment.
The patient's presentation of nasal congestion, rhinorrhea, and dry cough for 4 days with normal vital signs and clear lungs is the hallmark of an acute viral upper respiratory tract infection (URI). The appropriate management for a viral URI is symptom relief (e.g., NSAIDs, saline irrigation, decongestants) and reassurance. Antibiotics are strictly contraindicated unless criteria for acute bacterial rhinosinusitis are met, which include symptoms lasting >10 days, severe symptoms for at least 3 consecutive days, or a biphasic 'double sickening' pattern.

Step-by-Step Solution

1
Evaluate the duration and severity of the patient's symptoms.
The patient has mild upper respiratory symptoms (congestion, rhinorrhea, cough) lasting only 4 days without fever or purulent discharge.
Symptom duration and severity are the primary factors in differentiating self-limiting viral upper respiratory infections from bacterial rhinosinusitis.
2
Assess the physical examination findings.
Vitals are completely normal, and lung auscultation is clear, ruling out pneumonia, asthma exacerbation, or COPD exacerbation.
Normal physical findings localize the illness to the upper respiratory tract and exclude lower respiratory pathology.
3
Determine the most appropriate management based on the diagnosis.
The diagnosis is an acute viral upper respiratory infection (common cold), which requires only supportive and symptomatic care.
Antibiotics are not indicated for viral infections and provide no clinical benefit while exposing the patient to unnecessary side effects.

Key Concept

Uncomplicated acute viral upper respiratory tract infections (URI) should be managed with supportive care and reassurance, without the use of antibiotics.
Question 1975Question →

During morning rounds in the surgical intensive care unit, a physician reviews the microbiological data for a patient recovering from an emergency laparotomy. The patient, a 67-year-old female, underwent surgery six days prior for perforated diverticulitis. At that time, she presented in septic shock and was resuscitated with intravenous fluids, vasopressors, and empiric broad-spectrum coverage utilizing vancomycin and piperacillin-tazobactam. Her clinical status has steadily improved; she was extubated on postoperative day 3 and is currently hemodynamically stable without vasoactive medications. Current vital signs show a temperature of 37.8°C (100.0°F). The electronic medical record flags a new critical result: blood cultures drawn 48 hours ago demonstrate growth of *Enterobacter cloacae*. The laboratory reports the isolate is susceptible to ceftriaxone, ceftazidime, cefepime, piperacillin-tazobactam, and meropenem. It shows resistance to ampicillin and first-generation cephalosporins. Based on these findings, which of the following is the most appropriate modification to her pharmacotherapy?

Show answer & explanation

Answer: Switch the regimen to intravenous cefepime only

Answer

Switch the regimen to intravenous cefepime only.
The most appropriate action is to switch the regimen to intravenous cefepime only. The patient has a bloodstream infection caused by *Enterobacter cloacae*. This organism, along with *Klebsiella aerogenes* and *Citrobacter freundii*, typically harbors a chromosomal gene for AmpC beta-lactamase. While these organisms often test susceptible to third-generation cephalosporins (like ceftriaxone) *in vitro*, these antibiotics act as strong inducers of the AmpC enzyme and are susceptible to hydrolysis by it. Using them in vivo for a high-inoculum or serious infection (like bacteremia) frequently results in the rapid selection of derepressed mutants and subsequent treatment failure. Cefepime, a fourth-generation cephalosporin, is a weak inducer of AmpC and is highly stable against hydrolysis by the enzyme, making it the drug of choice. Vancomycin can be safely discontinued because the causative pathogen has been fully identified as a Gram-negative bacillus.

Step-by-Step Solution

1
Evaluate the microbiology results.
Blood cultures are positive for Enterobacter cloacae, a Gram-negative bacillus known to harbor an inducible chromosomal AmpC beta-lactamase.
Identifying the specific pathogen allows for targeted antimicrobial therapy.
2
Analyze the resistance profile and implications for therapy.
Although ceftriaxone and piperacillin-tazobactam appear susceptible in vitro, they are highly associated with clinical failure in serious AmpC infections due to enzyme induction or weak inhibition.
In vitro susceptibility does not always equal in vivo clinical success, especially for AmpC-producing organisms.
3
Select the most appropriate targeted agent.
Cefepime is selected because it is a weak inducer of AmpC and is stable against hydrolysis. Vancomycin is discontinued as there is no Gram-positive pathogen.
Cefepime provides definitive efficacy while practicing good antimicrobial stewardship by sparing carbapenems.

Key Concept

Treatment of serious infections caused by organisms with inducible AmpC beta-lactamases (e.g., Enterobacter, Klebsiella aerogenes, Citrobacter freundii) requires agents that are weak inducers and stable against hydrolysis, such as cefepime or carbapenems. Third-generation cephalosporins should be avoided despite apparent in vitro susceptibility.
Estimated Time:1m 15s
Question 1976Question →

Autoantibody testing plays a critical role in the diagnosis and classification of connective tissue diseases. Match each specific autoantibody profile to the rheumatologic condition it is most strongly associated with.

Click a left item, then click its matching right item

Items

Anti-cyclic citrullinated peptide (anti-CCP)
Anti-double-stranded DNA (anti-dsDNA)
Anti-centromere
Anti-Jo-1 (histidyl-tRNA synthetase)

Matches

Show answer & explanation

Answer

Anti-CCP matches with Rheumatoid arthritis; Anti-dsDNA matches with Systemic lupus erythematosus; Anti-centromere matches with Limited cutaneous systemic sclerosis; Anti-Jo-1 matches with Polymyositis / Dermatomyositis.
The correct matches represent foundational, high-yield serologic associations required for diagnosing classic rheumatologic conditions. Each autoantibody serves as a highly specific diagnostic criterion for its respective connective tissue disease.

Step-by-Step Solution

1
Identify the primary disease association for anti-CCP antibodies.
Matches with rheumatoid arthritis.
Anti-CCP is the most specific marker for rheumatoid arthritis.
2
Identify the primary disease association for anti-dsDNA antibodies.
Matches with systemic lupus erythematosus.
Anti-dsDNA is highly specific for SLE and correlates with renal involvement.
3
Identify the primary disease association for anti-centromere antibodies.
Matches with limited cutaneous systemic sclerosis.
This is the classic marker for limited SSc (CREST syndrome), distinguishing it from diffuse SSc which is associated with anti-Scl-70.
4
Identify the primary disease association for anti-Jo-1 antibodies.
Matches with polymyositis / dermatomyositis.
Anti-Jo-1 is an antisynthetase antibody characteristic of inflammatory myopathies.

Key Concept

Foundational Serologic Markers in Rheumatologic Diseases
Question 1977Question →

Match each classic peripheral blood smear finding to the hematologic disorder with which it is most characteristically associated.

Click a left item, then click its matching right item

Items

Bite cells and Heinz bodies
Hypersegmented neutrophils
Auer rods
Smudge cells
Schistocytes

Matches

Show answer & explanation

Answer

The correct pairings connect hallmark morphologic features on the peripheral smear to their underlying pathophysiology: Bite cells/Heinz bodies with G6PD deficiency, Hypersegmented neutrophils with Vitamin B12 deficiency, Auer rods with AML, Smudge cells with CLL, and Schistocytes with TTP.
Each classic peripheral blood smear finding directly represents the underlying pathophysiology of its respective hematologic disorder, testing foundational clinical knowledge required for accurate diagnosis.

Step-by-Step Solution

1
Analyze the peripheral smear finding for 'Bite cells and Heinz bodies'.
Matched with G6PD deficiency.
These indicate oxidative damage to red blood cells, the core mechanism of G6PD deficiency.
2
Analyze 'Hypersegmented neutrophils'.
Matched with Vitamin B12 deficiency.
Hypersegmentation is a hallmark of impaired DNA synthesis and megaloblastic anemias.
3
Analyze 'Auer rods'.
Matched with Acute myeloid leukemia (AML).
Auer rods are the pathognomonic finding in immature myeloblasts.
4
Analyze 'Smudge cells'.
Matched with Chronic lymphocytic leukemia (CLL).
Fragile lymphocytes are easily ruptured during the physical smearing process in CLL.
5
Analyze 'Schistocytes'.
Matched with Thrombotic thrombocytopenic purpura (TTP).
Fragmented red blood cells are the hallmark of intravascular shearing in microangiopathic hemolytic anemias.

Key Concept

Peripheral blood smear interpretation in hematologic disorders
Estimated Time:1m 0s
Question 1978Question →

Match the following distinct peripheral blood smear findings to their most likely underlying clinical condition or pathophysiology.

Click a left item, then click its matching right item

Items

Teardrop-shaped red blood cells (dacrocytes) and nucleated red blood cells
Bite cells (degmacytes) and Heinz bodies
Hypersegmented neutrophils (≥ 5 lobes) and macroovalocytes
Schistocytes (fragmented red blood cells) and severe thrombocytopenia

Matches

Show answer & explanation

Answer

Teardrop cells pair with Primary myelofibrosis; Bite cells pair with Glucose-6-phosphate dehydrogenase deficiency; Hypersegmented neutrophils pair with Vitamin B12 or folate deficiency; Schistocytes pair with Thrombotic thrombocytopenic purpura.
Each peripheral smear finding is directly linked to its underlying pathophysiology. Marrow fibrosis causes teardrop cells; oxidative stress in G6PD deficiency causes Heinz bodies and bite cells; DNA synthesis defects cause megaloblastic changes; and microvascular thrombosis causes schistocytes.

Step-by-Step Solution

1
Analyze the peripheral smear finding of teardrop cells and nucleated red blood cells.
Matches Primary myelofibrosis.
Bone marrow fibrosis forces RBC precursors to squeeze through tight spaces, deforming them into teardrop shapes (dacrocytes).
2
Analyze the peripheral smear finding of bite cells and Heinz bodies.
Matches Glucose-6-phosphate dehydrogenase deficiency.
Oxidative damage precipitates hemoglobin (Heinz bodies), which splenic macrophages remove, leaving a 'bite' out of the cell.
3
Analyze the finding of hypersegmented neutrophils and macroovalocytes.
Matches Vitamin B12 or folate deficiency.
Defective DNA synthesis leads to megaloblastic changes, resulting in large RBCs and hypersegmentation of neutrophil nuclei.
4
Analyze the finding of schistocytes and thrombocytopenia.
Matches Thrombotic thrombocytopenic purpura.
Platelet-rich microthrombi shear passing RBCs in the microvasculature, producing fragmented cells (schistocytes).

Key Concept

Recognition of classic peripheral blood smear findings is essential for diagnosing specific hematologic disorders, including structural marrow abnormalities, enzyme deficiencies, maturation defects, and microangiopathic processes.
Question 1979Question →

A 29-year-old man is brought to the emergency department by his partner due to the sudden onset of right-sided weakness and difficulty speaking that began 22 hours ago. Over the past 66 months, the patient has experienced profound fatigue and intermittent episodes of difficulty swallowing. He also reports vague, episodic abdominal pain and passing very dark urine, which he notes is most prominent during his first void of the morning. His temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 132/82 mm Hg132/82 \text{ mm Hg}, pulse is 98/min98/\text{min}, and respiratory rate is 16/min16/\text{min}. Physical examination reveals mild scleral icterus, right-sided hemiparesis, and expressive aphasia. The abdomen is soft and non-tender. Laboratory studies show:

Hemoglobin: 7.8 g/dL7.8 \text{ g/dL}
Mean corpuscular volume: 99 fL99 \text{ fL}
Platelet count: 122,000/mm3122,000/\text{mm}^3
Leukocyte count: 3,800/mm33,800/\text{mm}^3
Lactate dehydrogenase: 2,100 U/L2,100 \text{ U/L}
Total bilirubin: 3.8 mg/dL3.8 \text{ mg/dL}
Direct bilirubin: 0.5 mg/dL0.5 \text{ mg/dL}
Haptoglobin: <10 mg/dL<10 \text{ mg/dL}
Creatinine: 1.3 mg/dL1.3 \text{ mg/dL}
Direct antiglobulin (Coombs) test: Negative

A non-contrast CT scan of the head shows no acute intracranial hemorrhage. Which of the following is the most appropriate diagnostic test to establish the underlying etiology of this patient's presentation?

Show answer & explanation

Answer: Flow cytometry of peripheral blood cells

Answer

Flow cytometry of peripheral blood cells
The patient's clinical picture of chronic intravascular hemolysis (elevated LDH, indirect hyperbilirubinemia, decreased haptoglobin, negative Coombs test), mild cytopenias, smooth muscle dystonia (dysphagia, abdominal pain), and acute arterial thrombosis (ischemic stroke) is highly specific for paroxysmal nocturnal hemoglobinuria (PNH). PNH is caused by an acquired mutation in the PIGA gene within a hematopoietic stem cell. This mutation results in an inability to synthesize glycosylphosphatidylinositol (GPI) anchors, which normally secure complement-inhibiting proteins (CD55 and CD59) to the cell surface. The absence of these proteins renders red blood cells highly susceptible to complement-mediated destruction. The resulting massive release of free hemoglobin scavenges circulating nitric oxide, leading to smooth muscle spasms that manifest as dysphagia, abdominal pain, and erectile dysfunction. Furthermore, the disorder creates a severely hypercoagulable state responsible for life-threatening venous and arterial thromboses. The gold standard for establishing the underlying etiology is flow cytometry of peripheral blood cells to demonstrate the absence of CD55 and CD59.

Step-by-Step Solution

1
Analyze the laboratory findings
High LDH, predominantly indirect hyperbilirubinemia, low haptoglobin, and a negative Coombs test indicate non-immune intravascular hemolysis.
Differentiating intravascular from extravascular and immune from non-immune hemolysis narrows the differential diagnosis.
2
Correlate hemolysis with the patient's symptoms
The presence of dark morning urine (hemoglobinuria), dysphagia, and abdominal pain aligns with nitric oxide depletion secondary to free hemoglobin in the plasma.
Smooth muscle dystonia (esophageal spasm, abdominal pain) is a classic complication of severe intravascular hemolysis.
3
Integrate the acute presentation with the chronic symptoms
The combination of intravascular hemolysis, pancytopenia (mild leukopenia and thrombocytopenia), and an unprovoked arterial thrombosis (ischemic stroke) forms the classic triad of paroxysmal nocturnal hemoglobinuria (PNH).
PNH is a highly hypercoagulable state that can present with atypical venous (Budd-Chiari) or arterial (stroke) thromboses.
4
Select the appropriate confirmatory diagnostic test
Flow cytometry of peripheral blood is chosen to confirm the diagnosis.
Flow cytometry directly identifies the absence of GPI-anchored complement inhibitors (CD55 and CD59) on the surface of blood cells.

Key Concept

Diagnosis of paroxysmal nocturnal hemoglobinuria (PNH)
Estimated Time:2m 0s
Question 1980Question →

A 22-year-old man with type 1 diabetes mellitus is brought to the emergency department with abdominal pain, nausea, and confusion. He recently had a respiratory infection. His blood pressure is 90/60 mm Hg, and heart rate is 122/min. Point-of-care capillary blood glucose is 550 mg/dL. An arterial blood gas reveals a pH of 7.15 and a bicarbonate of 10 mEq/L. The remainder of his laboratory results, including a basic metabolic panel, are pending. Arrange the following management steps in the most appropriate chronological order for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Administer rapid intravenous fluid resuscitation with 0.9% normal saline, verify that the serum potassium concentration is ≥3.3\geq 3.3 mEq/L, initiate a continuous intravenous infusion of regular insulin, add 5% dextrose to the intravenous fluid composition, and finally transition to a subcutaneous insulin regimen.
The correct chronological sequence for managing diabetic ketoacidosis (DKA) prioritizes physiological stabilization and avoids iatrogenic complications. Severe volume depletion must be addressed immediately with intravenous normal saline to restore perfusion. Before insulin can be administered to halt ketogenesis, the serum potassium level must be verified as ≥3.3\geq 3.3 mEq/L to prevent fatal intracellular shifts. Once safe, a continuous regular insulin infusion is started. As the blood glucose falls below 200 mg/dL, 5% dextrose is added to the fluids to prevent hypoglycemia while the insulin continues to close the anion gap. Finally, once the anion gap is closed and the patient can eat, they are transitioned to a subcutaneous insulin regimen.

Step-by-Step Solution

1
Identify the patient's primary diagnosis and immediate life-threatening physiological derangement.
The patient has diabetic ketoacidosis (DKA) with significant volume depletion, evidenced by hypotension (90/60 mm Hg) and tachycardia.
Severe dehydration and acidosis must be addressed first to restore tissue perfusion.
2
Select the first line of acute management.
Administer rapid intravenous fluid resuscitation with 0.9% normal saline.
Restoring intravascular volume is the most critical initial step, which also helps lower blood glucose by improving renal perfusion and glucose excretion.
3
Determine the prerequisite for insulin therapy.
Verify that the serum potassium concentration is ≥3.3\geq 3.3 mEq/L from the pending basic metabolic panel.
DKA causes a total body potassium deficit. Insulin drives potassium intracellularly; giving insulin to a hypokalemic patient can trigger fatal arrhythmias.
4
Initiate therapy to halt ketogenesis.
Initiate a continuous intravenous infusion of regular insulin.
Once potassium levels are confirmed safe, insulin is required to stop lipolysis, halt ketone production, and close the anion gap.
5
Determine how to prevent hypoglycemia during continued insulin therapy.
Add 5% dextrose to the intravenous fluid composition when blood glucose drops below 200 mg/dL.
Insulin must be continued to close the anion gap even after blood glucose normalizes. Adding dextrose prevents iatrogenic hypoglycemia during this process.
6
Plan the long-term transition out of the acute crisis.
Transition to a subcutaneous insulin regimen.
Once the anion gap is closed, the patient is clinically stable, and can eat, they can safely be transitioned off the continuous intravenous infusion.

Key Concept

The management of diabetic ketoacidosis follows a strict protocol prioritizing volume resuscitation, verification of potassium stores to prevent fatal arrhythmias, insulin administration to close the anion gap, and eventual addition of dextrose to prevent hypoglycemia.
PreviousPage 99 / 414Next
All practice questions — USMLE Step 2 CK | Examkin